Due to COVID-19 we are now offering TeleHealth Office Visits via video or phone call. Learn More >
We have prepared for the Coronavirus (COVID-19). We have updated policies to protect our patients and staff. Learn more.

Metastatic Prostate Cancer Outcomes Can Depend on Location: Study

Many of the 180,000 American men who will face down a diagnosis of prostate cancer this year will find they have a highly treatable, low-risk form of the disease, Some, however, will come to learn their disease is more aggressive and has already spread to other locations within the body. The diagnosis does not necessarily mean tragic results though. Advanced treatments may make a very big difference as can the specific location of the spread.

Researchers recently looked into the outcomes of men with metastasis to the prostatic anterior fat pad lymph nodes. Studies have found men who present with this type of metastasis tend to have less severe outcomes than men with a detected spread to other areas of the body, such as the pelvic lymph nodes. Another study showed that outcomes in men with fat pad metastasis were positive in many cases when aggressive treatment was performed.

Courtesy of early screening protocols, most men who test positive for prostate cancer will find their disease is caught in the earliest, most treatable stage. Some forms of prostate cancer, however, are more aggressive than others. The best treatment recommendations will hinge on the specifics of a patient’s case, including tumor size, location and evidence of spread. Should metastatic prostate cancer be detected, doctors will aim to treat not only the original prostate cancer but also the area in which the spread has been found.

All men are technically at risk for the development of prostate cancer. This disease is most commonly diagnosed in men later in life. Early screening is recommended for men starting between the ages of 40 to 50. Specific recommendations may hinge on a man’s personal risk factors for developing prostate cancer. Men who are diagnosed with the disease should discuss all treatment options with their healthcare providers.


More Choice Cancer Care Centers